Ozempic Is Facing $2 Billion in Lawsuits. Here's Why.

I'm starting something new here. A series called Debunking Wellness, where I take the health trends everyone's been sold and actually look at what's underneath them.

First up. Ozempic.

What's actually happening

This isn't a rumor or a wellness influencer hot take. Nearly 4,000 lawsuits are currently pending against Novo Nordisk, the maker of Ozempic. Legal analysts project total liability could exceed $2 billion. Plaintiffs allege the company knew about serious risks, including stomach paralysis, gallbladder disease, pancreatitis and a form of vision loss but didn't adequately warn patients while marketing the drug for weight loss far beyond its original diabetes use.

No settlements have been reached yet and no trials have been completed to date. But the sheer volume of cases growing by hundreds every few months, tells you this isn't a fringe concern.

Why this matters beyond the lawsuit itself

Ozempic became a cultural phenomenon almost overnight. Celebrity use, social media, and a desire for a fast answer turned a diabetes medication into a lifestyle drug for millions of people who were never given the full picture of what they were opting into.

Here's what I keep coming back to. A drug that suppresses appetite doesn't address why your body is holding onto weight, struggling with blood sugar, or feeling exhausted in the first place. It mutes the signal without ever asking what the signal was trying to tell you.

I'm not here to shame anyone who's used it or considering it. I'm here to say the promise of a shortcut always comes with a cost, and right now, thousands of people are living that cost in real time.

Why these drugs exist in the first place

GLP-1 is actually a hormone your gut already makes. Researchers discovered it in the 1980s and found it helps your pancreas release insulin when blood sugar rises, which is exactly what fails in people with type 2 diabetes. The problem was the natural hormone breaks down in the body almost immediately, so scientists spent years building a synthetic, longer-acting version that could actually work as a treatment. That's what became Ozempic, approved for diabetes in 2017.

The weight loss piece was originally a side effect noticed in diabetes trials, not the reason the drug was built. It wasn't until 2021 that semaglutide got its own separate approval specifically for weight loss, under the name Wegovy. And that's when the cultural explosion really took off.

Here's a distinction most people don't realize. Ozempic and Wegovy are the same drug made by the same company. Ozempic is approved for diabetes. Wegovy is approved for weight loss. Same drug, two names, two different approvals. So when someone without diabetes takes Ozempic specifically to lose weight, they're technically using it off-label, even though the same company (Novo Nordisk) already sells the same drug under a different name (Wegovy) for exactly that purpose. Doctors are actually prescribing the Ozempic product itself to non-diabetic patients, often because it's cheaper or easier to get than Wegovy. 

There's a practical wrinkle to prescribing too. Ozempic is capped at a lower maximum dose than Wegovy, since it was never built to go higher. Ozempic was dosed for blood sugar control, not maximum weight loss. So a doctor prescribing Ozempic off-label is working with a lower ceiling than the same drug is actually capable of at Wegovy's higher dose. That's part of why weight loss results are noticeably smaller on Ozempic than on Wegovy, even though it's the identical medication. In practice, this means a lot of prescribing decisions come down to cost and insurance coverage rather than a clean medical protocol, which is a big part of why this space feels like the wild west right now. Everyone's working from the same drug, but the dose, the label, and the oversight all shift depending on what gets approved, what's affordable, and what a given prescriber is comfortable doing off-label.

And Ozempic isn't the only player anymore either. This is a whole drug class now. Eli Lilly makes tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, and it's currently showing even stronger weight loss results in trials than semaglutide. There's also liraglutide (Victoza and Saxenda), dulaglutide (Trulicity), and newer entries still arriving. The lawsuits in this post are specifically about Novo Nordisk's semaglutide products, not the entire category, but it's worth knowing this is bigger than one brand name.

What the side effects actually are

The common ones are the ones you've probably already heard about. Nausea, vomiting, diarrhea and constipation, especially when starting out or increasing the dose. Most people are told these improve over time, though they can flare up again every time the dose goes up.

The serious ones are what the lawsuits are actually about. Gastroparesis, where the stomach stops emptying properly, causing severe, persistent vomiting. Gallbladder disease, sometimes requiring surgery. Pancreatitis. A specific form of sudden vision loss called NAION, usually affecting one eye and often permanent. The drug's label also carries a warning about a risk of thyroid tumors, based on animal studies, which is why it's not recommended for anyone with a personal or family history of certain thyroid cancers.

There's also a quieter risk that gets far less attention than it deserves, bone density loss and fracture risk, which we'll get into next.

The risk in using it for weight loss alone

Roughly 1 in 8 US adults have taken a GLP-1 drug at some point. About 15 million people are currently on one right now. That's not a niche trend, that's a meaningful share of the entire country on a medication that's simultaneously facing thousands of lawsuits.

This is the part that gets lost in the marketing. These drugs were tested and dosed around specific medical conditions, diabetes and obesity, under a doctor's supervision. A huge portion of current use is happening outside of that. When Ozempic and Wegovy were in short supply, compounding pharmacies stepped in to make their own versions from raw ingredients, legally, but without the same manufacturing standards or consistent oversight as the actual approved drug. A lot of people got semaglutide this way, through telehealth companies, without a doctor closely monitoring them.

And here few specific risks worth knowing. These drugs are built to be taken indefinitely. Research shows people regain roughly 60 percent of the weight they lost within a year of stopping, because the drug was managing appetite, not fixing what caused the weight gain in the first place. Obesity medicine guidelines now describe these as long-term, likely lifelong medications for that reason.

They also don't just burn fat. Studies show 40 to 60 percent of the weight lost on these drugs can be lean muscle mass, not fat. There's growing research linking them to a meaningful increase in bone density loss and fracture risk, especially in older adults and women. This research was serious enough that the FDA added a warning about it to semaglutide's label. Rapid weight loss without enough protein, resistance exercise and monitoring can leave someone lighter on the scale but weaker and more fragile everywhere else.

None of this means the drug has no place in medicine. It has a real one, for the condition it was actually built for. But using it as a shortcut around lifestyle change, without medical supervision, is a different thing entirely than what the original science was for.

What actually works, without the lawsuit

Real, whole food and consistent movement were never the risky option. They were just slower and slower doesn't sell as well. Fruit, vegetables, beans and whole grains don't have massive marketing budgets behind them but they are what work best for your long term health and vitality. 

This is exactly the conversation I want to keep having in this series and it's part of why I'm bringing Clean & Green back this fall. A real reset, built on food and habits your body actually recognizes, not a drug you'll be reading about in a class action years from now.

More on that soon.

Whitney is a certified holistic nutritionist, plant-based chef, raw juice alchemist and certified yoga instructor with 8 years of experience helping women nourish their bodies and align their lives. She is the founder of Eat Plants & Prosper.